Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CHPA Agenda 2014: Monograph Reform, NSURE Progress

This article was originally published in The Tan Sheet

Executive Summary

The Consumer Healthcare Products Association plans to tackle big tasks in 2014, including working with FDA to improve the monograph system, move the new Rx-to-OTC switch paradigm forward and determine quality metrics to help FDA better target inspections. The trade group also is looking for ways to ease pricing pressures and ensure quality does not suffer.

Advertisement

Related Content

In Brief: Helen Of Troy In Supplements; J&J Innovation; U.K. Ad Enforcement; CHPA Chairman-elect; Hispanic Consumer Health
In Brief: Helen Of Troy In Supplements; J&J Innovation; U.K. Ad Enforcement; CHPA Chairman-elect; Hispanic Consumer Health
House Pushes FDA To Expedite Sunscreen Ingredient Reviews
Sanofi’s Nasacort First-In-Class Switch Receives FDA Approval
CHPA Petitions For Acetaminophen Under-2 Dose Labeling
Oxytrol For Women Gets OTC Green Light As Rare First-In-Class Switch
Pediatric Acetaminophen Panel Debates Execution Of Dosing Changes
Pediatric Acetaminophen Expanded Dosing Requested In McNeil Petition

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS106900

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel